Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
The Clinical Picture

Trident sign in osmotic demyelination syndrome

Erin Equinozzi, MSc, Clement D. Lee, MD, MSc and Pamela Schaefer, MD
Cleveland Clinic Journal of Medicine December 2025, 92 (12) 732-733; DOI: https://doi.org/10.3949/ccjm.92a.24080
Erin Equinozzi
Tufts University School of Medicine, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clement D. Lee
Department of Medicine, Newton-Wellesley Hospital, Newton, MA; Tufts University School of Medicine, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: clee112{at}partners.org
Pamela Schaefer
Department of Radiology, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

A 43-year-old man with alcohol use disorder presented to the emergency department with abdominal distension and weight loss. Physical examination was notable for an abdominal fluid wave, pitting edema of both lower extremities, and spider angiomas on the upper chest and neck. Laboratory testing showed thrombocytopenia with a platelet count of 60 × 109/L (reference range 135–400), hypokalemia with a potassium level of 3.0 mmol/L (3.5–5.2), and hyponatremia with a sodium level of 109 mmol/L (136–145).

He was admitted to the intensive care unit, and hypertonic saline was started. The patient’s sodium level was 112 mmol/L after 24 hours and 120 mmol/L after 48 hours. He experienced agitation, which was attributed to alcohol withdrawal, and empiric lactulose was administered.

One week later, rhythmic movements of his extremities were observed. Electroencephalography showed cortical irritability in the right temporal region. Magnetic resonance imaging of the brain showed a “trident sign,” suggesting osmotic demyelination syndrome (Figure 1).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

(A) There is a confluent trident-shaped lesion (arrow) in the central pons that is hyperintense on fluid-attenuated inversion recovery magnetic resonance imaging. (B) Additionally, the lesion (arrow) is hyperintense on diffusion-weighted imaging and (C) hypointense (arrow) on apparent diffusion coefficient imaging, consistent with restricted diffusion due to cytotoxic edema.

The patient’s seizures were controlled with the anticonvulsants levetiracetam, clobazam, and lacosamide. He was ultimately discharged to his home with rehabilitative services and medical therapy that included levetiracetam, lactulose, rifaximin, ciprofloxacin, and propranolol.

OSMOTIC DEMYELINATION SYNDROME

Osmotic demyelination syndrome describes the neurologic manifestations that may accompany sudden osmotic shifts in the brain, most commonly due to correction of chronic hyponatremia.1 Brain cells adapt to chronic hyponatremia by releasing electrolytes and organic osmolytes, causing water to move out of the cells and equalizing the solute concentration between the cell and the extracellular fluid.1 During correction of hyponatremia, osmolytes move into glia more slowly than electrolytes; rapid correction of hyponatremia creates an acute osmotic imbalance (rising sodium levels with lagging osmolar uptake) that results in myelin damage and cell death, classically in the pons.1

The presentation of osmotic demyelination syndrome is often biphasic. The initial encephalopathy that is related to severe hyponatremia improves with sodium correction, which is followed by neurologic deterioration up to 7 days later,1 as seen in our patient. Osmotic demyelination syndrome was once diagnosed by autopsy; however, magnetic resonance imaging has increased antemortem diagnosis and led to improved prognosis.2

Diagnostic clues

Diagnosis of osmotic demyelination syndrome relies on recognizing risk factors and typical imaging findings. Risk factors for osmotic demyelination syndrome include hypokalemia, chronic alcohol use disorder, malnutrition, and cirrhosis.1 Hypokalemia leads to downregulation of sodium-potassium adenosine triphosphatase, the enzyme that pumps sodium ions out of the cell and potassium ions in, so cells cannot readily respond to rapid sodium shifts. Alcohol use and malnutrition delay the regeneration of osmoles that the brain uses as buffers.1

Classic findings of osmotic demyelination syndrome on magnetic resonance imaging include confluent hypointensity on T1-weighted imaging, hyperintensity on T2-weighted imaging, and diffusion restriction within the central pons, in a trident configuration, sparing the periphery and corticospinal tracts.1,2 Changes in T1- and T2-weighted imaging can take 2 weeks to appear, but diffusion restriction may appear soon after clinical symptoms emerge.1 Magnetic resonance imaging findings may take weeks to improve but typically do not resolve.3

Cerebral spinal fluid, if obtained, is generally unremarkable.4

Differential diagnosis

The differential diagnosis in this patient included hepatic encephalopathy, posterior reversible encephalopathy syndrome, and Wernicke encephalopathy. Hepatic encephalopathy generally exhibits diffuse cerebral edema, sparing the perirolandic and occipital regions, and should improve with lactulose treatment. Posterior reversible encephalopathy syndrome is associated with blood pressure fluctuations (not prominent in this patient) and typically shows vasogenic edema in the parieto-occipital lobes or borderline zones and rarely involves the brainstem. Wernicke encephalopathy characteristically involves the mammillary bodies, dorsomedial thalami, quadrigeminal plate, periaqueductal gray matter, and hypothalamus, and presents with ophthalmoplegia and ataxia, which were not seen in our patient.5

There are radiographic mimics of osmotic demyelination syndrome that are also characterized by encephalopathy, seizures, and additional corticospinal or bulbar weakness. Restricted diffusion in acute pontine ischemia is typically unilateral rather than central. Demyelinating disease is usually also accompanied by demyelination in the posterior fossa and supratentorial brain regions. Brainstem encephalitis and tumors are typically expansile. Metabolic derangements usually also involve other regions of the brain.5

With no proven therapies, prevention is key

Guidelines recommend correcting serum sodium by less than 8 mmol/L in any 24-hour period in patients with risk factors for osmotic demyelination syndrome.6 Interestingly, osmotic demyelination syndrome is more correlated with the peak change in serum sodium and less with 24-hour changes.7

There are no proven therapies for osmotic demyelination syndrome; management includes supportive care and rehabilitation services. Favorable outcomes are reported in about half of patients, with many achieving full independence.2

DISCLOSURES

The authors report no relevant financial relationships which, in the context of their contributions, could be perceived as a potential conflict of interest.

  • Copyright © 2025 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. Kumar S,
    2. Fowler M,
    3. Gonzalez-Toledo E,
    4. Jaffe SL
    . Central pontine myelinolysis, an update. Neurol Res 2006; 28(3):360–366. doi:10.1179/016164106X110346
    OpenUrlCrossRefPubMed
  2. ↵
    1. Singh TD,
    2. Fugate JE,
    3. Rabinstein AA
    . Central pontine and extrapontine myelinolysis: a systematic review. Eur J Neurol 2014; 21(12):1443–1450. doi:10.1111/ene.12571
    OpenUrlCrossRefPubMed
  3. ↵
    1. Menger H,
    2. Jörg J
    . Outcome of central pontine and extrapontine myelinolysis (n = 44). J Neurol 1999; 246(8):700–705. doi:10.1007/s004150050435
    OpenUrlCrossRefPubMed
  4. ↵
    1. Tarhan NC,
    2. Agildere AM,
    3. Benli US,
    4. Ozdemir FN,
    5. Aytekin C,
    6. Can U
    . Osmotic demyelination syndrome in end-stage renal disease after recent hemodialysis: MRI of the brain. AJR Am J Roentgenol 2004; 182(3): 809–816. doi:10.2214/ajr.182.3.1820809
    OpenUrlCrossRefPubMed
  5. ↵
    1. Sarbu N,
    2. Shih RY,
    3. Jones RV,
    4. Horkayne-Szakaly I,
    5. Oleaga L,
    6. Smirniotopoulos JG
    . White matter diseases with radiologic-pathologic correlation. Radiographics 2016; 36(5):1426–1447. doi:10.1148/rg.2016160031
    OpenUrlCrossRefPubMed
  6. ↵
    1. Sterns RH,
    2. Rondon-Berrios H,
    3. Adrogué HJ, et al
    . Treatment guidelines for hyponatremia: stay the course. Clin J Am Soc Nephrol 2024; 19(1):129–135. doi:10.2215/CJN.0000000000000244
    OpenUrlCrossRefPubMed
  7. ↵
    1. Verbalis JG,
    2. Martinez AJ
    . Neurological and neuropathological sequelae of correction of chronic hyponatremia. Kidney Int 1991; 39(6):1274–1282. doi:10.1038/ki.1991.161
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 92 (12)
Cleveland Clinic Journal of Medicine
Vol. 92, Issue 12
1 Dec 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Trident sign in osmotic demyelination syndrome
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
Please verify that you are a real person.
Citation Tools
Trident sign in osmotic demyelination syndrome
Erin Equinozzi, Clement D. Lee, Pamela Schaefer
Cleveland Clinic Journal of Medicine Dec 2025, 92 (12) 732-733; DOI: 10.3949/ccjm.92a.24080

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Trident sign in osmotic demyelination syndrome
Erin Equinozzi, Clement D. Lee, Pamela Schaefer
Cleveland Clinic Journal of Medicine Dec 2025, 92 (12) 732-733; DOI: 10.3949/ccjm.92a.24080
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget

Jump to section

  • Article
    • OSMOTIC DEMYELINATION SYNDROME
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Skin manifestations of mpox
  • Acute transient phlebitis after a morphine infusion
Show more The Clinical Picture

Similar Articles

Subjects

  • Neurology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire